[dr-data]

Found it already! In today's news:

> Currently, a number of randomised trials which test aspirin and mortality are in progress. These focus upon the common cancers: colon, breast, prostate and one in lung cancer. One of these trials, based upon 3021 selected patients in remission from a HER2-negative breast cancer, has already reported [31]. This trial was ended prematurely because aspirin was associated with a possible increase of about 25% in deaths.

[chefandy]

Classic baby/bathwater disposal problem. There are plenty of medicines that are beneficial for some applications but harmful for others. Maybe all of them, to some extent? That's why the authors wrote dozens of other sentences in that article.